SAVA
NASDAQ · Pharmaceuticals
Cassava Sciences Inc
$1.00
+0.04 (+3.75%)
Open$0.96
Previous Close$0.96
Day High$1.03
Day Low$0.93
52W High$4.98
52W Low$0.86
Volume—
Avg Volume287.3K
Market Cap114.97M
P/E Ratio—
EPS$-2.20
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 22.84M | 20.47M | 21.96M |
| Net Income | 4.14M | 5.17M | 4.25M |
| Profit Margin | 18.1% | 25.2% | 19.3% |
| EBITDA | 7.09M | 5.98M | 7.27M |
| Free Cash Flow | 3.09M | 2.63M | 3.14M |
| Rev Growth | -6.9% | +1.2% | +18.5% |
| Debt/Equity | 1.35 | 1.36 | 1.39 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |